SEARCH
 

Stock Exchange Announcements

Which news do you want to read?
April 24 2008 / Stock exchange announcement

Group financial statement for first quarter of 2008: Growth continues for Novozymes

2008 kicked off with high sales growth, leading to an upwards adjustment in local currencies. Expected sale of enzymes for detergents and feed significantly increased. Despite unfavorable exchange rates, the outlook for net profit 2008 in DKK is maintained.

March 06 2008 / Stock exchange announcement

Annual meeting of shareholders 2008

March 06 2008 / Stock exchange announcement

Trading by management in Novozymes A/S B shares

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transaction under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.

February 08 2008 / Stock exchange announcement

Trading by management in Novozymes A/S B shares

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.

February 06 2008 / Stock exchange announcement

Major shareholder announcement

January 31 2008 / Stock exchange announcement

Trading by management in Novozymes A/S B shares

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.

January 30 2008 / Stock exchange announcement

Management trading 2008, no. 1

In accordance with Section 28a of the Danish Securities Trading Act, Novozymes reports the following transactions under ISIN DK0010272129, Novozymes B shares under the symbol NZYM B.

January 25 2008 / Stock exchange announcement

Group financial statement for 2007

2007 was a really good year for Novozymes. Growth was the theme of the year, with sales growth higher than expected at 14%. The financial results were satisfactory, particularly in the light of high energy and raw material prices. Unfavorable exchange rate movements had a negative impact on the results measured in DKK. Growth in earnings was 11%, and free cash flow was DKK 963 million. The high rate of sales growth is expected to continue in 2008 and onwards, and therefore it has been decided to expand the production in the USA.

2008 FINANCIAL CALENDAR

January 25, 2008
Group financial statement, FY 2008

March 5, 2008
Annual shareholders' meeting

April 24, 2008
Group financial statement, Q1 2008

August 14, 2008
Group financial statement, H1 2008

October 31, 2008
Group financial statement, 9M 2008

Copyright © 2008 Novozymes.